Cover Image
市場調查報告書

內臟器官保存的全球市場 ∼2021年:保存液、各運輸手法、內臟器官的各種類的分析與預測

Organ Preservation Market by Preservation Solution(UW/Custodiol HTK/Perfadex), Transportation Technique (Static Cold Storage/Hypothermic Machine Perfusion/Normothermic Machine Perfusion) & Organ Type(Kidneys/liver/lung) - Analysis & Forecasts to 2021

出版商 MarketsandMarkets 商品編碼 364596
出版日期 內容資訊 英文 128 Pages
訂單完成後即時交付
價格
Back to Top
內臟器官保存的全球市場 ∼2021年:保存液、各運輸手法、內臟器官的各種類的分析與預測 Organ Preservation Market by Preservation Solution(UW/Custodiol HTK/Perfadex), Transportation Technique (Static Cold Storage/Hypothermic Machine Perfusion/Normothermic Machine Perfusion) & Organ Type(Kidneys/liver/lung) - Analysis & Forecasts to 2021
出版日期: 2016年07月25日 內容資訊: 英文 128 Pages
簡介

全球內臟器官保存市場,2015年達1億6590萬美元,預計2021年達2億4120萬美元,以7.8%的年複合成長率 (CAGR) 成長。由於近幾年的技術進步使內臟器官易於保存,及人口高齡化導致多重器官功能衰竭患者增加,全球各地器官移植手術的數量增加,也導致內臟器官保存、移植市場成長。另一方面,器官移植手術費用高額,也可能妨礙市場成長。

本報告提供可移植的內臟器官的保存、運輸手段的全球市場相關分析,市場基本結構和最新趨勢,主要市場促進、阻礙因素,市場趨勢與今後的預測 (過去2年、今後6年份),按保存液、按手法、內臟器官的各類型、各地區的詳細趨勢,市場競爭的狀態,今後的技術開發、市場發展的方向性,主要企業簡介等調查、考察。

第1章 簡介

第2章 分析方法

第3章 摘要整理

第4章 重要考察

第5章 內臟器官保存的全球市場:概要

  • 簡介
  • 市場動態
    • 推動因素
      • 隨著人口高齡化,多器官功能衰竭的發病數量增加
      • 技術進步
      • 政府、NGO的器官移植的促進活動
      • 實質內臟器官的移植治療的數量增加
    • 阻礙因素
      • 器官移植的費用高
    • 市場機會
      • 正常體溫機器灌流:內臟器官保存的新範例
    • 課題
      • 提供內臟器官和等待患者的差距大
      • 對內臟器官提供、移植的醫療費償付的限制

第6章 可移植內臟器官保存、運輸市場:各保存液

  • 簡介
  • UW保存液 (威斯康星州大學保存液)
  • CUSTODIOL HTK
  • PERFADEX
  • 其他保存液

第7章 可移植內臟器官保存、運輸市場:各手法

  • 簡介
  • 靜態低溫貯存 (SCS) 手法
  • 低體溫機器灌流
  • 正常體溫機器灌流

第8章 可移植內臟器官保存、運輸市場:內臟器官的各類型

  • 簡介
  • 腎臟
  • 肝臟
  • 心臟
  • 其他的內臟器官 (胰臟、腸)

第9章 可移植內臟器官保存、運輸市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • (英國、西班牙、義大利、德國)歐洲主要4個國家
    • 其他的歐洲各國
  • 亞太地區
    • 中國
    • 其他的亞太地區各國
  • 其他的國家 (RoW) (巴西、沙烏地阿拉伯、伊朗、以色列)

第10章 競爭環境

  • 概要
  • 競爭情形與趨勢
    • 產品開發
    • 認證、證明
    • 產業擴張
    • 其他策略

第11章 企業簡介

  • 簡介
  • PARAGONIX TECHNOLOGIES, INC.
  • 21ST CENTURY MEDICINE INC.
  • DR. FRANZ KOHLER CHEMIE GMBH
  • ESSENTIAL PHARMACEUTICALS, LLC
  • LIFELINE SCIENTIFIC, INC. (ORGAN RECOVERY SYSTEMS, INC.)
  • PRESERVATION SOLUTIONS, INC.
  • XVIVO PERFUSION AB
  • TRANSMEDICS, INC.
  • ORGANOX LIMITED
  • BRIDGE TO LIFE LIMITED
  • WATERS MEDICAL SYSTEMS LLC INSTITUT GEORGES LOPEZ (IGL)

第12章 附錄

目錄
Product Code: MD 4464

The organ preservation market is expected to reach USD 241.2 million in 2021 from USD 165.9 million in 2015 at a CAGR of 7.8%. Over the years, the organ preservation market, has witnessed various technological advancements. These advancements have led to a growth in the number of transplants across the globe. Some of the other factors driving the growth of the market are rising multi-organ failure cases in aging population, rising solid organ transplantation procedures, and increasing government initiatives to promote organ donation. However, the high cost of transplants is a factor that is hindering the market.

In 2016, the University of Wisconsin segment is expected to account for the largest share of the organ preservation market, by preservation solution. This large share can be attributed to its prolific usage in the storage of kidney, liver, and pancreas, better transplantation outcomes, less histological damage, and improved physiological function of organs. The static cold storage is expected to account for the largest share of the organ preservation market, by technique. The largest share of static cold storage can be attributed to the simplicity, low cost, and less requirement of equipment and trained personnel. Kidneys to account for the largest share, by organ type. The large share can be attributed to factors such as rising cases of kidney failure, improvements in graft survival, and long-term graft function.

In 2016, North America is expected to account for the largest share of the global organ preservation market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Its large share can be attributed to growing cases of kidney failure, rising organ transplants, favorable reimbursements scenario within some provinces in Canada, and novel technological advancements by U.S. players. In the coming years, the organ preservation market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in these regions can be attributed to the new regulatory framework in China, and increasing organ donations in Asia-Pacific.

The global organ preservation market witnesses various product offerings offered by big and small firms. Client acquisitions, approvals, market expansions were the key developments undertaken by the companies to increase their market shares and to establish a strong foothold in the global market. The major players in this market include Organ Recovery Systems (U.S.), Xvivo Perfusion AB (Sweden), Essential Pharmaceuticals LLC (U.S.), Dr. Franz Kohler Chemie GmbH (Germany), and Waters Medical Systems LLC (U.S.), among others.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios and services offered by the top 10 players in the organ preservation market. The report analyzes organ transplants by preservation solution, technique and organ type.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the organ preservation market.
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various preservation solutions and techniques across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the organ preservation market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the organ preservation market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key Insights from primary sources
      • 2.2.2.3. Key industry insights
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. RESEARCH DESIGN
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. CURRENT SCENARIO
  • 3.2. FUTURE OUTLOOK
  • 3.3. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. TRANSPLANTABLE ORGAN PRESERVATION AND TRANSPORT MARKET
  • 4.2. GEOGRAPHIC ANALYSIS
  • 4.3. TRANSPLANTABLE ORGAN PRESERVATION AND TRANSPORT MARKET, BY TECHNIQUE (2016KKKKK VS. 2021)
  • 4.4. TRANSPLANTABLE ORGAN PRESERVATION AND TRANSPORT MARKET, BY SOLUTION (2016KKKKK VS. 2021)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising cases of multiple organ failure in aging population
      • 5.2.1.2. Technological advancements
      • 5.2.1.3. Increasing government and NGO initiatives to encourage organ donation
      • 5.2.1.4. Rising number of solid-organ transplantation procedures
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High cost of organ transplantation
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Normothermic machine perfusion: a new paradigm for organ preservation
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Significant gap between number of organs donated and organs required annually
      • 5.2.4.2. Limited medical reimbursements for organ donation and transplantation

6. TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET, BY PRESERVATION SOLUTION

  • 6.1. INTRODUCTION
  • 6.2. UNIVERSITY OF WISCONSIN SOLUTION (UW SOLUTION)
  • 6.3. CUSTODIOL HTK
  • 6.4. PERFADEX
  • 6.5. OTHER PRESERVATION SOLUTIONS

7. TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET, BY TECHNIQUE

  • 7.1. INTRODUCTION
  • 7.2. STATIC COLD STORAGE (SCS) TECHNIQUE
  • 7.3. HYPOTHERMIC MACHINE PERFUSION
  • 7.4. NORMOTHERMIC MACHINE PERFUSION

8. TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET, BY ORGAN TYPE

  • 8.1. INTRODUCTION
  • 8.2. KIDNEYS
  • 8.3. LIVER
  • 8.4. LUNG
  • 8.5. HEART
  • 8.6. OTHER ORGANS (PANCREAS, INTESTINE)

9. TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
      • 9.2.1.1. Novel technological advancements by U.S. players
      • 9.2.1.2. Growing cases of kidney failure in the U.S.
      • 9.2.1.3. Huge gap between demand and supply of organs
    • 9.2.2. CANADA
      • 9.2.2.1. Rising organ transplants
      • 9.2.2.2. Favorable reimbursement scenario for living donors within some provinces in Canada
  • 9.3. EUROPE
    • 9.3.1. E-4. (U.K., SPAIN, ITALY & GERMANY)
      • 9.3.1.1. Active participation of the Spanish National Transplant Organization (ONT)
      • 9.3.1.2. Changes in organ donation laws in Wales (U.K.)
      • 9.3.1.3. Transplant scandal in Germany
    • 9.3.2. REST OF EUROPE
      • 9.3.2.1. Awareness campaigns in Europe
      • 9.3.2.2. Lack of organ donations in Denmark
      • 9.3.2.3. Family refusal, the primary barrier for organ donation in France
  • 9.4. ASIA-PACIFIC
    • 9.4.1. CHINA
      • 9.4.1.1. New regulatory framework boosts voluntary organ donation
      • 9.4.1.2. Wastage of organs
    • 9.4.2. REST OF ASIA-PACIFIC
      • 9.4.2.1. Increasing organ donation in Australia
      • 9.4.2.2. Lack of awareness and religious beliefs in India & Japan
  • 9.5. REST OF THE WORLD (ROW)
    • 9.5.1. CAMPAIGNS IN BRAZIL TO ENCOURAGE ORGAN DONATION
    • 9.5.2. FAVORABLE REGULATORY ENVIRONMENT IN SAUDI ARABIA, IRAN, AND ISRAEL

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. COMPETITIVE SITUATION AND TRENDS
    • 10.2.1. PRODUCT DEPLOYMENTS
    • 10.2.2. APPROVALS AND CERTIFICATIONS
    • 10.2.3. EXPANSIONS
    • 10.2.4. OTHER STRATEGIES

11. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 11.1. INTRODUCTION
  • 11.2. PARAGONIX TECHNOLOGIES, INC.
  • 11.3. 21ST CENTURY MEDICINE INC.
  • 11.4. DR. FRANZ KOHLER CHEMIE GMBH
  • 11.5. ESSENTIAL PHARMACEUTICALS, LLC
  • 11.6. LIFELINE SCIENTIFIC, INC. (ORGAN RECOVERY SYSTEMS, INC.)
  • 11.7. PRESERVATION SOLUTIONS, INC.
  • 11.8. XVIVO PERFUSION AB
  • 11.9. TRANSMEDICS, INC.
  • 11.10. ORGANOX LIMITED
  • 11.11. BRIDGE TO LIFE LIMITED
  • 11.12. WATERS MEDICAL SYSTEMS LLC [INSTITUT GEORGES LOPEZ (IGL)]

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE OF GLOBAL TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET
  • 12.2. OTHER DEVELOPMENTS, BY COMPANY (2012-2015)
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • 12.4.1. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: NUMBER OF KIDNEY TRANSPLANTS PERFORMED ACROSS VARIOUS GEOGRAPHIES (2012-2014)
  • TABLE 2: NUMBER OF LIVER TRANSPLANTS PERFORMED ACROSS VARIOUS GEOGRAPHIES (2012-2014)
  • TABLE 3: NUMBER OF LUNG TRANSPLANTS PERFORMED ACROSS VARIOUS GEOGRAPHIES (2012-2014)
  • TABLE 4: TECHNOLOGICAL ADVANCEMENTS, THE PIVOTAL FACTOR PROPELLING THE GROWTH OF THE TRANSPLANTABLE ORGAN STORAGE & TRANSPORT MARKET
  • TABLE 5: AVERAGE COST OF KIDNEY TRANSPLANTS FOR VARIOUS COUNTRIES, 2016
  • TABLE 6: HIGH COST OF TRANSPLANT PROCEDURES RESTRAINING MARKET GROWTH
  • TABLE 7: NORMOTHERMIC MACHINE PERFUSION IN ORGAN PRESERVATION OFFERS AN ARRAY OF OPPORTUNITIES FOR THE TRANSPLANTABLE ORGAN STORAGE & TRANSPORT MARKET
  • TABLE 8: SIGNIFICANT GAP BETWEEN DEMAND AND SUPPLY OF ORGANS, A MAJOR CHALLENGE FOR THE MARKET
  • TABLE 9: GLOBAL TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY PRESERVATION SOLUTION, 2014-2021 (USD MILLION)
  • TABLE 10: UW SOLUTION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: NORTH AMERICAN UW SOLUTION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 12: EUROPEAN UW SOLUTION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: ASIA-PACIFIC UW SOLUTION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: CUSTODIOL HTK SOLUTION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: NORTH AMERICAN CUSTODIOL HTK SOLUTION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 16: EUROPEAN CUSTODIOL HTK SOLUTION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: ASIA-PACIFIC CUSTODIOL HTK SOLUTION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 18: PERFADEX SOLUTION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: NORTH AMERICAN PERFADEX SOLUTION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 20: EUROPEAN PERFADEX SOLUTION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: ASIA-PACIFIC PERFADEX SOLUTION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: OTHER PRESERVATION SOLUTIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: NORTH AMERICAN OTHER PRESERVATION SOLUTIONS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: EUROPEAN OTHER PRESERVATION SOLUTIONS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: ASIA-PACIFIC OTHER PRESERVATION SOLUTIONS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: GLOBAL TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 27: ADVANTAGES AND DISADVANTAGES OF THE SCS TECHNIQUE OF PRESERVATION OF TRANSPLANTABLE ORGANS
  • TABLE 28: STATIC COLD STORAGE (SCS) TECHNIQUE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: ADVANTAGES AND DISADVANTAGES OF THE HMP TECHNIQUE OF PRESERVATION OF TRANSPLANTABLE ORGANS
  • TABLE 30: HYPOTHERMIC MACHINE PERFUSION (HMP) MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: ADVANTAGES AND DISADVANTAGES OF THE NMP TECHNIQUE OF PRESERVATION OF TRANSPLANTABLE ORGANS
  • TABLE 32: NORMOTHERMIC MACHINE PERFUSION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: GLOBAL TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY ORGAN TYPE, 2014-2021 (USD MILLION)
  • TABLE 34: TRANSPLANT MARKET SIZE FOR KIDNEYS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: TRANSPLANT MARKET SIZE FOR LIVER, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: TRANSPLANT MARKET SIZE FOR LUNGS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 37: TRANSPLANT MARKET SIZE FOR HEARTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: TRANSPLANT MARKET SIZE FOR OTHER ORGANS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: NORTH AMERICA: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: NUMBER OF KIDNEY TRANSPLANTS IN THE U.S., 2012-2015
  • TABLE 42: WAITING LIST OF CANDIDATES FOR ORGAN TRANSPLANTATION IN THE U.S. (AS OF JULY 2016)
  • TABLE 43: U.S.: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY PRESERVATION SOLUTION, 2014-2021 (USD MILLION)
  • TABLE 44: U.S.: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 45: U.S.: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY ORGAN TYPE, 2014-2021 (USD MILLION)
  • TABLE 46: ORGAN TRANSPLANTS PERFORMED IN CANADA (2012-2014)
  • TABLE 47: CANADA: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY PRESERVATION SOLUTION, 2014-2021 (USD MILLION)
  • TABLE 48: CANADA: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 49: CANADA: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY ORGAN TYPE, 2014-2021 (USD MILLION)
  • TABLE 50: EUROPE: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: E-4: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY PRESERVATION SOLUTION, 2014-2021 (USD MILLION)
  • TABLE 52: E-4: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 53: E-4: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY ORGAN TYPE, 2014-2021 (USD MILLION)
  • TABLE 54: ROE: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY PRESERVATION SOLUTION, 2014-2021 (USD MILLION)
  • TABLE 55: ROE: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 56: ROE: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY ORGAN TYPE, 2014-2021 (USD MILLION)
  • TABLE 57: ASIA-PACIFIC: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 58: CHINA: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY PRESERVATION SOLUTION, 2014-2021 (USD MILLION)
  • TABLE 59: CHINA: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 60: CHINA: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY ORGAN TYPE, 2014-2021 (USD MILLION)
  • TABLE 61: ROAPAC: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY PRESERVATION SOLUTION, 2014-2021 (USD MILLION)
  • TABLE 62: ROAPAC: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 63: ROAPAC: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY ORGAN TYPE, 2014-2021 (USD MILLION)
  • TABLE 64: NUMBER OF ORGAN DONATIONS (2008 VS. 2015)
  • TABLE 65: ROW: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY PRESERVATION SOLUTION, 2014-2021 (USD MILLION)
  • TABLE 66: ROW: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 67: ROW: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY ORGAN TYPE, 2014-2021 (USD MILLION)
  • TABLE 68: PRODUCT DEPLOYMENTS, 2013-2016
  • TABLE 69: APPROVALS AND CERTIFICATIONS, 2013-2016
  • TABLE 70: EXPANSIONS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND COUNTRY FOR SUPPLY SIDE
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY ORGANIZATION TYPE, DESIGNATION, AND REGION FOR DEMAND SIDE
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 7: RESEARCH DESIGN
  • FIGURE 8: DATA TRIANGULATION METHODOLOGY
  • FIGURE 9: NORTH AMERICA IS EXPECTED TO DOMINATE THE TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET IN 2016
  • FIGURE 10: HYPOTHERMIC MACHINE PERFUSION SEGMENT TO GROW AT THE HIGHEST CAGR FROM 2016 TO 2021
  • FIGURE 11: ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 12: GROWTH OPPORTUNITIES IN THE TRANSPLANTABLE ORGAN PRESERVATION AND TRANSPORT MARKET (2016-2021)
  • FIGURE 13: ASIA-PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 14: STATIC COLD STORAGE TECHNIQUE TO COMMAND LARGEST SHARE IN 2016
  • FIGURE 15: UNIVERSITY OF WISCONSIN (UW) SOLUTION TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: MARKET SEGMENTATION
  • FIGURE 17: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SEGMENTATION, BY PRESERVATION SOLUTION
  • FIGURE 18: THE UNIVERSITY OF WISCONSIN SOLUTION TO ACCOUNT FOR THE LARGEST SHARE OF THE TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET IN 2016
  • FIGURE 19: GLOBAL TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SEGMENTATION, BY TECHNIQUE
  • FIGURE 20: STATIC COLD STORAGE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF MEDICAL ANIMATION MARKET (2016-2021)
  • FIGURE 21: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SEGMENTATION, BY ORGAN TYPE
  • FIGURE 22: KIDNEYS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET (2016-2021)
  • FIGURE 23: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE GLOBAL TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET IN 2016
  • FIGURE 24: NORTH AMERICAN TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET OVERVIEW
  • FIGURE 25: EUROPEAN TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET OVERVIEW
  • FIGURE 26: ASIA-PACIFIC TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET OVERVIEW 91  
  • FIGURE 27: ROW TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET OVERVIEW
  • FIGURE 28: PRODUCT DEPLOYMENT WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS IN THE LAST THREE YEARS
  • FIGURE 29: PRODUCT MIX OF KEY PLAYERS
  • FIGURE 30: LIFELINE SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • FIGURE 31: XVIVO PERFUSION AB: COMPANY SNAPSHOT
Back to Top